Medical Marijuana, Inc. Launches Pharma Subsidiary in Brazil; Expands Access to CBD Products in Pharmacies
SAN DIEGO, CA, May 26, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that it has launched its first pharmaceutical subsidiary, HM Pharma , in Brazil. “We have been working hard to connect and build meaningful relationships with medical professionals and consumers in Brazil. This new sales channel will open new avenues for continued growth by bringing our cannabidiol (CBD) products to pharmacies throughout the country,” said Matheus Patelli, Managing Director of HM Pharma. “Not only will our products be more affordable than other CBD products sold at drugstores in Brazil, but they will be of the highest quality.” In Brazil, CBD is currently permitted only for medical use with authorization from the country’s Nationa...